Dr. Mikhail Vinogradov, MD

Dr. Vinogradov practices at Tidelands Georgetown Memorial Hospital in Georgetown, South Carolina, part of Medical University of South Carolina.

Dr. Vinogradov's NPI, 1073518452, was assigned on June 14, 2005. Dr. Vinogradov holds South Carolina license 36916.

Dr. Vinogradov's primary practice is Tidelands Georgetown Memorial Hospital, at 606 Black River Rd Drawer 1718, Georgetown, SC 29440 in Georgetown County. The practice phone is (843) 527-7000.

Dr. Vinogradov's primary practice is Tidelands Georgetown Memorial Hospital in Georgetown, South Carolina, part of Medical University of South Carolina. Dr. Vinogradov is also affiliated with MUSC Health University Medical Center. The medical group on file is Tidelands Georgetown Memorial Hospital. Dmand AI also links Dr. Vinogradov to 3 more hospitals, 3 medical groups, 2 group practices and clinics, 1 home health agency and 1 hospital outpatient department, each named with a free account. Dr. Vinogradov's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vinogradov practices, 9 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Vinogradov's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Vinogradov's licenses on file in 2 states: South Carolina and Virginia.

CMS data shows 2,055 Medicare services from Dr. Vinogradov across 7 procedure codes in 2024, for 370 Medicare patients. Medicare paid $99,541 for them. Every service was in an office.

CMS counts 370 Medicare patients who saw Dr. Vinogradov in 2024. The largest group is 65 to 74, with 179 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vinogradov's median patient age at 72, with 61% women.

In 2024, Dr. Vinogradov wrote 1,544 Medicare Part D claims for 222 patients. 84% of them were for generic drugs. CMS names the drug for 1,247 of them, across 34 drugs with 11 or more claims each, at $2,733,188 in total drug cost. In 2023, CMS named 978 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Vinogradov for performance year 2024, reported as part of a group. Dr. Vinogradov accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vinogradov as offering telehealth.

Dmand AI links 1 paper to Dr. Vinogradov in 2021. Dr. Vinogradov's most frequent co-authors are Lam T. Nguyen and Arminder Singh, MD.

Dmand AI links Dr. Vinogradov to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Rectal Neoplasms and Rectal Diseases.

CMS Open Payments shows 40 general payments to Dr. Vinogradov from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $156.